Low tumor mutational burden and immunotherapy in gliomas.
Publication
, Journal Article
Brown, MC; Ashley, DM; Khasraw, M
Published in: Trends Cancer
May 2022
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Trends Cancer
DOI
EISSN
2405-8025
Publication Date
May 2022
Volume
8
Issue
5
Start / End Page
345 / 346
Location
United States
Related Subject Headings
- Immunotherapy
- Humans
- Glioma
- Biomarkers, Tumor
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Brown, M. C., Ashley, D. M., & Khasraw, M. (2022). Low tumor mutational burden and immunotherapy in gliomas. Trends Cancer, 8(5), 345–346. https://doi.org/10.1016/j.trecan.2022.01.006
Brown, Michael C., David M. Ashley, and Mustafa Khasraw. “Low tumor mutational burden and immunotherapy in gliomas.” Trends Cancer 8, no. 5 (May 2022): 345–46. https://doi.org/10.1016/j.trecan.2022.01.006.
Brown MC, Ashley DM, Khasraw M. Low tumor mutational burden and immunotherapy in gliomas. Trends Cancer. 2022 May;8(5):345–6.
Brown, Michael C., et al. “Low tumor mutational burden and immunotherapy in gliomas.” Trends Cancer, vol. 8, no. 5, May 2022, pp. 345–46. Pubmed, doi:10.1016/j.trecan.2022.01.006.
Brown MC, Ashley DM, Khasraw M. Low tumor mutational burden and immunotherapy in gliomas. Trends Cancer. 2022 May;8(5):345–346.
Published In
Trends Cancer
DOI
EISSN
2405-8025
Publication Date
May 2022
Volume
8
Issue
5
Start / End Page
345 / 346
Location
United States
Related Subject Headings
- Immunotherapy
- Humans
- Glioma
- Biomarkers, Tumor
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis